• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素原作为川崎病静脉注射免疫球蛋白无反应的生物标志物。

Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.

机构信息

From the Department of Pediatrics, Aichi Medical University, Aichi, Japan.

出版信息

Pediatr Infect Dis J. 2020 Sep;39(9):857-861. doi: 10.1097/INF.0000000000002716.

DOI:10.1097/INF.0000000000002716
PMID:32433223
Abstract

OBJECTIVE

To investigate the usefulness of procalcitonin (PCT) as predictive factors of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease patients.

METHODS

We retrospectively analyzed the laboratory data from 215 children with Kawasaki disease treated with IVIG from 2014 to 2019. We analyzed the clinical and laboratory parameters just before the IVIG including serum levels of PCT with respect to the IVIG response.

RESULTS

Eventually, 127 patients were analyzed. The median age was 2.4 years. IVIG was effective in 108 children (responders) and was ineffective in 19 (non-responders). Serum PCT concentration was higher in non-responders than those of responders (P < 0.001). Multivariate logistic regression analyses indicated that higher PCT concentration (odds ratio 1.34, 95% confidence interval 1.10-1.64) were associated with IVIG resistance. Analyses of the receiver operating characteristic curve showed that the cutoff value of PCT 2.18 ng/mL had 46.4% of sensitivity and 93.9% of specificity. Receiver operating characteristic analysis yielded an area under the curve of 0.82 (0.72-0.92) to predict IVIG resistance.

CONCLUSIONS

Serum PCT value can be an excellent biomarker for predicting unresponsiveness to IVIG with a good discriminatory ability as well as the existing prediction scores.

摘要

目的

探讨降钙素原(PCT)作为预测静脉注射免疫球蛋白(IVIG)抵抗川崎病患者的有用指标。

方法

我们回顾性分析了 2014 年至 2019 年间 215 例接受 IVIG 治疗的川崎病患儿的实验室数据。我们分析了 IVIG 前的临床和实验室参数,包括 PCT 血清水平与 IVIG 反应的关系。

结果

最终分析了 127 例患儿。中位年龄为 2.4 岁。IVIG 对 108 例患儿(有效组)有效,对 19 例患儿(无效组)无效。无效组患儿 PCT 浓度高于有效组(P < 0.001)。多变量逻辑回归分析表明,较高的 PCT 浓度(比值比 1.34,95%置信区间 1.10-1.64)与 IVIG 抵抗相关。受试者工作特征曲线分析显示,PCT 截断值 2.18 ng/mL 的敏感性为 46.4%,特异性为 93.9%。受试者工作特征分析得出,预测 IVIG 抵抗的曲线下面积为 0.82(0.72-0.92)。

结论

血清 PCT 值可以作为预测 IVIG 无反应性的一个极好的生物标志物,具有良好的鉴别能力以及现有的预测评分。

相似文献

1
Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.降钙素原作为川崎病静脉注射免疫球蛋白无反应的生物标志物。
Pediatr Infect Dis J. 2020 Sep;39(9):857-861. doi: 10.1097/INF.0000000000002716.
2
Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.血清降钙素原对川崎病初始和重复免疫球蛋白抵抗的预测价值:一项前瞻性队列研究。
Pediatr Rheumatol Online J. 2019 Nov 27;17(1):78. doi: 10.1186/s12969-019-0379-5.
3
Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.降钙素原水平预测免疫球蛋白抵抗型川崎病对英夫利昔单抗的反应。
Cytokine. 2019 Feb;114:26-31. doi: 10.1016/j.cyto.2018.11.025. Epub 2018 Dec 21.
4
Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.预测川崎病患儿重复静脉注射免疫球蛋白治疗抵抗。
BMC Pediatr. 2021 Sep 16;21(1):406. doi: 10.1186/s12887-021-02876-w.
5
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
6
Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?降钙素原(PCT)与川崎病:PCT 是否与 IVIG 抵抗性疾病、入住重症监护病房或冠状动脉损伤的发展相关?
J Pediatric Infect Dis Soc. 2016 Sep;5(3):297-302. doi: 10.1093/jpids/piv019. Epub 2015 Apr 20.
7
Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.根据治疗前病程长短预测川崎病患者静脉注射免疫球蛋白耐药。
Eur J Pediatr. 2020 Feb;179(2):257-264. doi: 10.1007/s00431-019-03474-w. Epub 2019 Nov 12.
8
The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.年龄特异性 N 末端脑利钠肽前体 cutoff 值在预测川崎病静脉注射免疫球蛋白抵抗中的作用:一项前瞻性队列研究。
Pediatr Rheumatol Online J. 2019 Sep 18;17(1):65. doi: 10.1186/s12969-019-0368-8.
9
Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.C反应蛋白/白蛋白比值在预测静脉注射免疫球蛋白抵抗性川崎病中的价值——来自中国多机构研究的数据
Int Immunopharmacol. 2020 Dec;89(Pt A):107037. doi: 10.1016/j.intimp.2020.107037. Epub 2020 Nov 23.
10
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.降钙素原在川崎病中的临床意义:鉴别败血症和评估 IVIG 反应的有用候选指标。
Clin Exp Med. 2021 Nov;21(4):633-643. doi: 10.1007/s10238-021-00709-9. Epub 2021 Apr 11.

引用本文的文献

1
Effectiveness of Initial Corticosteroid Treatment in Kawasaki Disease Children Suspected to be IVIG Resistant.初始皮质类固醇治疗对疑似静脉注射免疫球蛋白无反应的川崎病患儿的有效性。
Pediatr Cardiol. 2024 Sep 24. doi: 10.1007/s00246-024-03657-9.
2
Combination of S100A12/TLR2 signaling molecules and clinical indicators in a new predictive model for IVIG-resistant Kawasaki disease.S100A12/TLR2 信号分子与临床指标联合构建 IVIG 抵抗川崎病的预测新模型。
Sci Rep. 2024 Mar 27;14(1):7261. doi: 10.1038/s41598-024-57897-z.
3
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
4
[Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].[静脉注射免疫球蛋白抵抗型川崎病患儿血清白细胞介素-17A的表达及其临床意义]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):244-249. doi: 10.7499/j.issn.1008-8830.2210151.
5
Kawasaki disease without changes in inflammatory biomarkers: A case report.炎症生物标志物无变化的川崎病:一例报告
World J Clin Cases. 2022 Dec 16;10(35):13038-13043. doi: 10.12998/wjcc.v10.i35.13038.
6
[Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].[川崎病急性期肝损伤与冠状动脉病变及静脉注射免疫球蛋白无反应的相关性]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jun 15;24(6):681-686. doi: 10.7499/j.issn.1008-8830.2112094.